Controversies in neuro-ophthalmic management
Descriptif détaillé : Controversies in neuro-ophthalmic management
This book functions as a resource for providers who treat patients with neuro-ophthalmic conditions.
What is the content of "Controversies in Neuro-Ophthalmic Management" ?
Using an evidence-based approach to controversial management decisions, the material is presented in a digestible, case-based format.
Divided into six sections, the book begins with an introduction to its framework, format, and purpose.
Following this, sections two, three, and four discuss various optic neuropathies, ocular motility disorders, and transient visual symptoms.
The concluding sections then address neuro-ophthalmic manifestations of pain, including migraine and post-concussive syndrome, and systemic diseases, such as giant cell arteritis.
Each chapter focuses on cases that are historically complex, or which have undergone a recent shift in traditional management due to new scientific discoveries or newly available therapies.
Who are the authors of "Controversies in Neuro-Ophthalmic Management" ?
Amanda D. Henderson, MD Johns Hopkins Wilmer Eye Institute
Dr. Henderson is an Assistant Professor of Ophthalmology and Neurology in the division of Neuro-Ophthalmology at the Wilmer Eye Institute at Johns Hopkins.
Her research focuses on optic neuropathies, specifically non-arteritic anterior ischemic optic neuropathy. She also has a particular interest in medical education and is the Neuro-Ophthalmology Fellowship Director, Associate Ophthalmology Residency Program Director, and Education Champion for the division of Neuro-Ophthalmology at Wilmer.
Andrew R. Carey, MD Johns Hopkins Wilmer Eye Institute
Andrew R. Carey, MD is an Assistant Professor of Ophthalmology in the division of Neuro-Ophthalmology at the Wilmer Eye Institute. He specializes in neuro-ophthalmic disorders such as optic neuritis, uveitis related papillitis, ischemic & hereditary optic neuropathies as well as diseases of the retina, including age-related macular degeneration, diabetic retinopathy, toxic retinopathies and inherited disorders of the retina such as retinitis pigmentosa.
Dr. Carey’s clinical and research interests include comparative effectiveness and cost-benefit of intravitreal medications, long-term outcome of treatments for choroidal neovascularization, novel treatments for papillitis, and the use of novel imaging modalities to better diagnose and understand optic nerve and retinal diseases.